Atlanta, Ga., Oct. 03, 2017 -- Blue Ridge, a provider of comprehensive, cloud-native supply chain planning solutions, today announced its user conference, BLUEPrint 2018, will be held in Atlanta on April 22 – April 24, 2017 at the Omni Hotel at The Battery Atlanta™. BLUEPrint is a hands-on annual conference for supply chain leaders, managers and users of Blue Ridge solutions.
The three-day event will feature innovative case studies on market-changing supply chain projects, hands-on educational sessions using Blue Ridge supply chain planning solutions, and valuable networking opportunities with supply chain leaders.
“Commerce is changing rapidly, and if your supply chain planning strategies were built with a ‘supply chain’ (back office operations) mentality and not a commerce-minded mentality (engaging the customer), then you need to rethink how you’re competing in today’s consumer-driven marketplace,” said Jim Byrnes, CEO of Blue Ridge. “BLUEPrint gives attendees actionable insights and hands-on strategies to take on the mega-brands and transform their operations to remain prepared and agile for continuous change in the retail and wholesale landscape.”
Anchored by SunTrust Park, the new home of the Atlanta Braves™, The Battery Atlanta is a unique sports and entertainment experience located in the bustling Cumberland area. For more information on BLUEPrint 2018, please visit blueridgeglobal.com/blueprint-2018.
About Blue Ridge
Blue Ridge provides revolutionary cloud-native supply chain planning technology specifically designed for retail and distribution. We enable our customers to increase revenue at lower costs by delivering an unprecedented level of precision and accuracy to forecast, plan and purchase inventory. Blue Ridge ensures products are available at the right time, without incurring excess inventory cost. For more information, go to www.blueridgeglobal.com.
Will Haraway Backbeat Marketing [email protected] 404.593.8320 www.backbeatmarketing.com


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



